Evogene said ChemPass AI was significantly expanded during 2025 through internal development and collaborations with Google Cloud
The therapy is currently completing Phase 1 clinical trials in renal cell carcinoma and non-small cell lung cancer
The partnership builds on a prior collaboration between Nimbus and Lilly targeting AMPK in cardiometabolic diseases
Agreement to co-develop artificial intelligence (AI) technology for the application in peptide drug design
The three-year collaboration will focus on the development of new tools for computational chemistry modelling as well as new molecular representations to advance the next generation of molecular machine learning
Using Orion, pharmaceutical and biotechnology companies, as well as any industrial researcher who wishes to perform electronic structure calculations, can gain access to elastic and flexible computational resources in the Cloud
Subscribe To Our Newsletter & Stay Updated
